sodium selenate has been researched along with u-50488 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakthavachalam, V; Bidlack, JM; Cohen, DJ; Gao, P; Mello, NK; Negus, SS; Neumeyer, JL; Zong, R | 1 |
| Bidlack, JM; Cohen, DJ; DeNunzio, NJ; Gu, XH; Mello, NK; Negus, SS; Neumeyer, JL; Rusovici, DE; van Vliet, LA | 1 |
| Bidlack, JM; Gu, XH; Hilbert, JE; Knapp, BI; Mello, NK; Negus, SS; Neumeyer, JL; Xiong, W; Zhang, A | 1 |
| Bidlack, JM; Knapp, BI; Neumeyer, JL; Peng, X | 3 |
| Bidlack, JM; Cohen, DJ; Knapp, BI; Neumeyer, JL; Sromek, AW; Zhang, B; Zhang, T | 1 |
7 other study(ies) available for sodium selenate and u-50488
| Article | Year |
|---|---|
Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine dependence.
Topics: Acetic Acid; Animals; Benzomorphans; Brain; Dose-Response Relationship, Drug; Ethylketocyclazocine; Guinea Pigs; In Vitro Techniques; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Morphinans; Morphine; Narcotic Antagonists; Pain; Pain Measurement; Reaction Time; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2000 |
Mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine abuse: synthesis and opioid receptor binding affinity of N-substituted derivatives of morphinan.
Topics: Cocaine-Related Disorders; Drug Combinations; Humans; Morphinans; Narcotic Antagonists; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2001 |
Design and synthesis of novel dimeric morphinan ligands for kappa and micro opioid receptors.
Topics: Animals; CHO Cells; Cricetinae; Dimerization; Drug Design; Humans; Ligands; Morphinans; Radioligand Assay; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship | 2003 |
High-affinity carbamate analogues of morphinan at opioid receptors.
Topics: Animals; Binding, Competitive; Carbamates; Cell Membrane; CHO Cells; Cricetinae; Cricetulus; Guanosine 5'-O-(3-Thiotriphosphate); Ligands; Morphinans; Narcotic Antagonists; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2007 |
Pharmacological properties of bivalent ligands containing butorphan linked to nalbuphine, naltrexone, and naloxone at mu, delta, and kappa opioid receptors.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; CHO Cells; Cricetinae; Cricetulus; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Morphinans; Nalbuphine; Naloxone; Naltrexone; Radioligand Assay; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship | 2007 |
In-vitro investigation of oxazol and urea analogues of morphinan at opioid receptors.
Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Magnetic Resonance Spectroscopy; Models, Molecular; Morphinans; Oxazoles; Receptors, Opioid; Urea | 2007 |
Synthesis, binding affinity, and functional in vitro activity of 3-benzylaminomorphinan and 3-benzylaminomorphine ligands at opioid receptors.
Topics: Animals; Benzylamines; Binding, Competitive; CHO Cells; Cricetinae; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Kinetics; Morphinans; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship | 2012 |